EA201990236A1 - Новые способы получения стимуляторов растворимой гуанилатциклазы - Google Patents

Новые способы получения стимуляторов растворимой гуанилатциклазы

Info

Publication number
EA201990236A1
EA201990236A1 EA201990236A EA201990236A EA201990236A1 EA 201990236 A1 EA201990236 A1 EA 201990236A1 EA 201990236 A EA201990236 A EA 201990236A EA 201990236 A EA201990236 A EA 201990236A EA 201990236 A1 EA201990236 A1 EA 201990236A1
Authority
EA
Eurasian Patent Office
Prior art keywords
stimulants
new methods
producing
soluble
guanilaticyclase
Prior art date
Application number
EA201990236A
Other languages
English (en)
Inventor
Сун Сюэ
Вишну Вардхан Редди Карнати
Роберт К. Ливингстон
Тимоти Клод Барден
Уэйн К. Шэйрер
Original Assignee
Сайклерион Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сайклерион Терапьютикс, Инк. filed Critical Сайклерион Терапьютикс, Инк.
Publication of EA201990236A1 publication Critical patent/EA201990236A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

Настоящее изобретение относится к новым способам получения соединений, полезных в качестве стимуляторов растворимой гуанилатциклазы (sGC). Эти способы поддаются крупномасштабному получению и дают стабильные 3-(2-пиримидинил)пиразолы формулы I, включая соединение I, соединение IA и соединение IB, с высокой чистотой и выходами. Настоящее изобретение обладает дополнительным преимуществом простых условий реакции, которые можно масштабировать для крупномасштабного производства. Изобретение также представляет новые промежуточные соединения, полезные при получении указанных соединений.
EA201990236A 2016-07-07 2017-07-06 Новые способы получения стимуляторов растворимой гуанилатциклазы EA201990236A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662359430P 2016-07-07 2016-07-07
PCT/US2017/040817 WO2018009602A2 (en) 2016-07-07 2017-07-06 Novel processes for preparation of soluble guanylate cyclase stimulators

Publications (1)

Publication Number Publication Date
EA201990236A1 true EA201990236A1 (ru) 2019-08-30

Family

ID=59351140

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990236A EA201990236A1 (ru) 2016-07-07 2017-07-06 Новые способы получения стимуляторов растворимой гуанилатциклазы

Country Status (17)

Country Link
US (1) US11834444B2 (ru)
EP (1) EP3481821B1 (ru)
JP (1) JP7054395B2 (ru)
KR (1) KR102513357B1 (ru)
CN (1) CN109563086B (ru)
AU (1) AU2017292811B2 (ru)
BR (1) BR112019000292A2 (ru)
CA (1) CA3029376A1 (ru)
CL (1) CL2019000017A1 (ru)
EA (1) EA201990236A1 (ru)
ES (1) ES2962829T3 (ru)
IL (1) IL263994B (ru)
JO (1) JOP20180126A1 (ru)
MA (1) MA45593A (ru)
MX (1) MX2019000138A (ru)
SG (2) SG11201900125PA (ru)
WO (1) WO2018009602A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11319308B2 (en) * 2016-07-07 2022-05-03 Cyclerion Therapeutics, Inc. Processes for preparation of soluble guanylate cyclase stimulators
WO2019161534A1 (en) * 2018-02-22 2019-08-29 Ironwood Pharmaceuticals, Inc. Novel processes and intermediates for preparation of soluble guanylate cyclase stimulators
MA51565A (fr) 2018-01-10 2020-11-18 Cyclerion Therapeutics Inc Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de la guanylate cyclase soluble

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101955439A (zh) * 2009-07-14 2011-01-26 华东理工大学 一种α-取代-2-氨基乙酰胺的拆分方法
CN107021951B (zh) 2010-06-30 2020-10-20 赛克里翁治疗有限公司 sGC刺激物
PL2663561T3 (pl) * 2011-01-13 2016-10-31 Nowe pochodne heterocykliczne i ich zastosowanie w leczeniu zaburzeń neurologicznych
EP2797915B1 (en) 2011-12-27 2016-07-13 Ironwood Pharmaceuticals, Inc. 2-benzyl-3-(oxazole/thiazole)-5-(pyrimidin-2-yl)-1(H)-pyrazole derivatives as stimulators of the soluble guanylate cyclase (sGC) for the treatment of e.g. hypertension or heart failure
HRP20220376T1 (hr) 2013-03-15 2022-07-22 Cyclerion Therapeutics, Inc. Sgc stimulatori
WO2016044447A1 (en) 2014-09-17 2016-03-24 Ironwood Pharmaceuticals, Inc. Pyrazole derivatives as sgc stimulators
CN108883071A (zh) 2015-11-30 2018-11-23 铁木医药有限公司 包含sGC刺激剂的固体分散体
CA3029333A1 (en) 2016-07-07 2018-01-11 Ironwood Pharmaceuticals, Inc. Solid forms of an sgc stimulator
US11319308B2 (en) 2016-07-07 2022-05-03 Cyclerion Therapeutics, Inc. Processes for preparation of soluble guanylate cyclase stimulators

Also Published As

Publication number Publication date
JP7054395B2 (ja) 2022-04-13
ES2962829T3 (es) 2024-03-21
WO2018009602A3 (en) 2018-03-15
US20210284632A1 (en) 2021-09-16
US11834444B2 (en) 2023-12-05
CN109563086B (zh) 2023-05-23
JOP20180126A1 (ar) 2019-01-30
SG11201900125PA (en) 2019-02-27
BR112019000292A2 (pt) 2019-04-16
CA3029376A1 (en) 2018-01-11
IL263994B (en) 2021-10-31
EP3481821C0 (en) 2023-09-06
IL263994A (en) 2019-01-31
EP3481821B1 (en) 2023-09-06
AU2017292811B2 (en) 2021-10-21
CL2019000017A1 (es) 2019-05-03
KR20190025987A (ko) 2019-03-12
MA45593A (fr) 2019-05-15
KR102513357B1 (ko) 2023-03-24
AU2017292811A1 (en) 2019-02-07
CN109563086A (zh) 2019-04-02
SG10202100168XA (en) 2021-02-25
WO2018009602A2 (en) 2018-01-11
JP2019524712A (ja) 2019-09-05
MX2019000138A (es) 2019-06-10
EP3481821A2 (en) 2019-05-15

Similar Documents

Publication Publication Date Title
MY172391A (en) Processes for preparing dihydropyrimidine derivatives and intermediates thereof
EA201990237A1 (ru) Новые способы получения стимуляторов растворимой гуанилатциклазы
MX2015002616A (es) Sintesis de bis(fluorosulfonil)imida.
NZ705827A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
EA201890522A1 (ru) Способ получения противогрибковых соединений
MX350892B (es) Síntesis de compuesto antiviral.
EA201990236A1 (ru) Новые способы получения стимуляторов растворимой гуанилатциклазы
EA201990688A1 (ru) Полиморфные формы соединения, представляющего собой ингибитор киназ, содержащая их фармацевтическая композиция, способ их получения и их применение
AR117002A2 (es) Proceso para la preparación de inhibidores de quinasa c-fms
AR090566A1 (es) Proceso para la produccion de inhibidores de crr
EA201490998A1 (ru) Способ получения сложных эфиров (5-фтор-2-метил-3-хинолин-2-илметил-индол-1-ил)-уксусной кислоты
CL2022000904A1 (es) Proceso para la preparación de compuestos representados por las fórmulas iv, vii y ia; y un polimorfo del compuesto de fórmula ia (div. sol. 202001814).
IN2014DN00144A (ru)
WO2018125983A8 (en) Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (acmsd) inhibitors
EP4282973A3 (en) Processes for the preparation of pyrimidinylcyclopentane compounds
AR095548A1 (es) Preparación de ácido 4-amino-2,4-dioxobutanoico
MX2021002896A (es) Proceso para preparar 1-(3,5-diclorofenil)-2,2,2-trifluoroetanona y sus derivados.
EA202091664A1 (ru) Новые способы и промежуточные соединения для получения стимуляторов растворимой гуанилатциклазы
WO2016059646A3 (en) Improved process for the preparation of 4- [6-amino-5-bromo-2- [(4-cvanophenyl) aminol]-4-pvrimidinvl]oxv]-3.5-dimethvlbenzonitrile
WO2016071920A3 (en) A process for preparation of 3,4-dimethylbenzaldehyde
MX2020002703A (es) Proceso mejorado para la preparacion de trifloxistrobina.
UA123716U (uk) Обетіхолева кислота
MX2021012713A (es) Procedimiento para la produccion de derivados de 2-[2-(fenil)etilamino]alcanamida sustituidos.
EA201500754A1 (ru) Замещенная (r)-3-(4-метилкарбамоил-3-фторфениламино)тетрагидрофуран-3-енкарбоновая кислота (варианты) и ее эфир, способ получения и применения
RU2013101109A (ru) Способ получения алкенилантрахинонов